Improving Access to Cancer Immunotherapy

Immunotherapy has transformed cancer treatment by harnessing the body’s immune system to fight the disease.

Yet, despite its potential, access to these therapies remains limited—particularly in low- and middle-income countries (LMICs), where cost barriers often prevent eligible patients from receiving life-saving treatments. In this comprehensive whitepaper, explore the current landscape of immuno-oncology and strategies to expand global access to immunotherapy.
 
Key insights include innovative pricing models, resource pooling, and value-based treatment research, offering pathways for biotech and pharma companies to improve accessibility and patient outcomes in immunotherapy worldwide.